BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
Hospital San Pedro
Logroño, EspañaPublicaciones en colaboración con investigadores/as de Hospital San Pedro (3)
2021
-
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
Blood Cancer Journal
-
The mutational landscape of acute myeloid leukaemia predicts responses and outcomes in elderly patients from the pethema-flugaza phase 3 clinical trial
Cancers, Vol. 13, Núm. 10